Continuous infusion of prostacyclin decreases plasma levels of t-PA and PAI-1 in primary pulmonary hypertension [7]

Thrombosis and Haemostasis

Volumn 73, Issue 4, 1995, Pages 735-736

  Boyer Neumann, C ^a   Brenot, F ^a   Wolf, M ^a   Peynaud Debayle, E ^a   Duroux, P ^a   Meyer, D ^a   Angles Cano, E ^a   Simonneau, G ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTACYCLIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; VASODILATATION;

EID: 0028946954     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1653857     Document Type: Letter

References (0)